KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Cash (2016 - 2025)

Historic Change in Cash for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$2.4 million.

  • Biolife Solutions' Change in Cash fell 21639.42% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 884.59%. This contributed to the annual value of $59.9 million for FY2024, which is 27632.14% up from last year.
  • Per Biolife Solutions' latest filing, its Change in Cash stood at -$2.4 million for Q3 2025, which was down 21639.42% from -$35.0 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Change in Cash registered a high of $71.2 million during Q4 2024, and its lowest value of -$35.3 million during Q2 2022.
  • Its 5-year average for Change in Cash is -$3.2 million, with a median of -$2.4 million in 2025.
  • As far as peak fluctuations go, Biolife Solutions' Change in Cash plummeted by 279791.67% in 2021, and later soared by 40794.3% in 2022.
  • Quarter analysis of 5 years shows Biolife Solutions' Change in Cash stood at -$5.4 million in 2021, then tumbled by 41.34% to -$7.7 million in 2022, then surged by 310.25% to $16.1 million in 2023, then soared by 341.96% to $71.2 million in 2024, then plummeted by 103.4% to -$2.4 million in 2025.
  • Its Change in Cash stands at -$2.4 million for Q3 2025, versus -$35.0 million for Q2 2025 and -$28.4 million for Q1 2025.